Bhumika Patel is an Oncology physician affiliated with Prisma Health. OpenAlex indexes 150 publications with 1,816 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
65 International Dr
Greenville, SC 296154816
Telephone
864-987-7000Provider last certified this registry record 21 Jun 2022.
Industry payments
53 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year202510 payments$14,097openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year202513 payments$12,450openpaymentsdata.cms.gov ↗
- Syndax Pharmaceuticals, Inc.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
30.6%Antimetabolite9.3%Hydroxyurea100%Part D≥13 patientsKinase inhibitor7.5%Brukinsa39%Calquence39%Jakafi22%Part D<11 patients+ 3 more classes in this area
Anti-infectives
17.1%Fluoroquinolone Antibacterial9.3%Levofloxacin100%Part D≥17 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor4.9%Valacyclovir100%Part D<11 patients+ 1 more class in this area
Musculoskeletal
12.6%Xanthine oxidase inhibitor12.6%Allopurinol100%Part D≥30 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria
Expert Opinion on Pharmacotherapy
2024 - NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022
Journal of the National Comprehensive Cancer Network
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Gopi Dandamudi, MD
Prisma Health
Ezequiel Gleichgerrcht, MD, PhD
Prisma Health
Anthony Gregg, MD
Prisma Health
Fredy Revilla, MD
Prisma Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”